The Analyst Verdict: Ocular Therapeutix In The Eyes Of 8 Experts
The Analyst Verdict: Ocular Therapeutix In The Eyes Of 8 Experts
分析师的判决：8位专家眼中的Ocular Therapeitix
Across the recent three months, 8 analysts have shared their insights on Ocular Therapeutix (NASDAQ:OCUL), expressing a variety of opinions spanning from bullish to bearish.
在最近三个月中，8位分析师分享了他们对Ocular Therapeutix（纳斯达克股票代码：OCUL）的见解，表达了从看涨到看跌的各种观点。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。
Analysts have recently evaluated Ocular Therapeutix and provided 12-month price targets. The average target is $17.5, accompanied by a high estimate of $24.00 and a low estimate of $11.00. This upward trend is apparent, with the current average reflecting a 66.67% increase from the previous average price target of $10.50.
分析师最近对Ocular Therapeutix进行了评估，并提供了12个月的目标股价。平均目标为17.5美元，最高估计值为24.00美元，低估值为11.00美元。这种上升趋势显而易见，当前的平均价格较之前的平均目标股价10.50美元上涨了66.67％。
Diving into Analyst Ratings: An In-Depth Exploration...
深入分析师评级：...
登录免费看全文
登录/注册